BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 31007034)

  • 1. Epidemiology, Risk Factors, and Outcomes After Early Posttransplant
    Jorgenson MR; Descourouez JL; Yang DY; Leverson GE; Saddler CM; Smith JA; Safdar N; Mandlebrot DA; Redfield RR
    Ann Pharmacother; 2019 Oct; 53(10):1020-1025. PubMed ID: 31007034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and Outcomes Associated With Clostridioides difficile Infection in Solid Organ Transplant Recipients.
    Hosseini-Moghaddam SM; Luo B; Bota SE; Husain S; Silverman MS; Daneman N; Brown KA; Paterson JM
    JAMA Netw Open; 2021 Dec; 4(12):e2141089. PubMed ID: 34964852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology, risk factors, and outcome of Clostridium difficile infection in heart and heart-lung transplant recipients.
    Bruminhent J; Cawcutt KA; Thongprayoon C; Petterson TM; Kremers WK; Razonable RR
    Clin Transplant; 2017 Jun; 31(6):. PubMed ID: 28314071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clostridioides difficile infection and recurrence among 2622 solid organ transplant recipients.
    Schluger A; Rosenblatt R; Knotts R; Verna EC; Pereira MR
    Transpl Infect Dis; 2019 Dec; 21(6):e13184. PubMed ID: 31571380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, Risk Factors, and Outcomes of Clostridium difficile Infections in Kidney Transplant Recipients.
    Li GJ; Trac J; Husain S; Famure O; Li Y; Kim SJ
    Transplantation; 2018 Sep; 102(9):1576-1581. PubMed ID: 29620613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Clostridium difficile Infection on Future Outcomes of Solid Organ Transplant Recipients.
    Luo R; Weinberg JM; Barlam TF
    Infect Control Hosp Epidemiol; 2018 May; 39(5):563-570. PubMed ID: 29553007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter, retrospective, case-cohort study of the epidemiology and risk factors for Clostridium difficile infection among cord blood transplant recipients.
    Alonso CD; Braun DA; Patel I; Akbari M; Oh DJ; Jun T; McMasters M; Hammond SP; Glotzbecker B; Cutler C; Leffler DA; Ballen KK; Kelly CP
    Transpl Infect Dis; 2017 Aug; 19(4):. PubMed ID: 28544102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and outcomes of Clostridium difficile infection in allogeneic hematopoietic cell and lung transplant recipients.
    Dubberke ER; Reske KA; Olsen MA; Bommarito K; Cleveland AA; Silveira FP; Schuster MG; Kauffman CA; Avery RK; Pappas PG; Chiller TM
    Transpl Infect Dis; 2018 Apr; 20(2):e12855. PubMed ID: 29427356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of Norovirus diarrheal infections and Clostridioides difficile infections in kidney transplant recipients: A single-center retrospective study.
    Rolak S; Di Bartolomeo S; Jorgenson MR; Saddler CM; Singh T; Astor BC; Parajuli S
    Transpl Infect Dis; 2019 Apr; 21(2):e13053. PubMed ID: 30689283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology, risk factors, and outcomes of Clostridium difficile infection in kidney transplant recipients.
    Neofytos D; Kobayashi K; Alonso CD; Cady-Reh J; Lepley D; Harris M; Desai N; Kraus E; Subramanian A; Treadway S; Ostrander D; Thompson C; Marr K
    Transpl Infect Dis; 2013 Apr; 15(2):134-41. PubMed ID: 23173772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridium difficile infection, a descriptive analysis of solid organ transplant recipients at a single center.
    Tsapepas DS; Martin ST; Miao J; Shah SA; Scheffert J; Fester K; Ma K; Lat A; Egan R; McKeen JT
    Diagn Microbiol Infect Dis; 2015 Apr; 81(4):299-304. PubMed ID: 25586932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clostridium difficile infection is associated with graft loss in solid organ transplant recipients.
    Cusini A; Béguelin C; Stampf S; Boggian K; Garzoni C; Koller M; Manuel O; Meylan P; Mueller NJ; Hirsch HH; Weisser M; Berger C; van Delden C;
    Am J Transplant; 2018 Jul; 18(7):1745-1754. PubMed ID: 29349869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospital-onset Clostridium difficile infection among solid organ transplant recipients.
    Donnelly JP; Wang HE; Locke JE; Mannon RB; Safford MM; Baddley JW
    Am J Transplant; 2015 Nov; 15(11):2970-7. PubMed ID: 26484839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin Prophylaxis for Prevention of Clostridium difficile Infection Recurrence in Renal Transplant Patients.
    Splinter LE; Kerstenetzky L; Jorgenson MR; Descourouez JL; Leverson GE; Saddler CM; Smith JA; Safdar N; Redfield RR
    Ann Pharmacother; 2018 Feb; 52(2):113-119. PubMed ID: 28844154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clostridium difficile infection increases mortality risk in lung transplant recipients.
    Lee JT; Kelly RF; Hertz MI; Dunitz JM; Shumway SJ
    J Heart Lung Transplant; 2013 Oct; 32(10):1020-6. PubMed ID: 23891145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential role of post-transplant hypogammaglobulinemia in the risk of Clostridium difficile infection after kidney transplantation: a case-control study.
    Origüen J; Fernández-Ruiz M; Lumbreras C; Orellana MÁ; López-Medrano F; Ruiz-Merlo T; San Juan R; García-Reyne A; González E; Polanco N; Paz-Artal E; Andrés A; Aguado JM
    Infection; 2015 Aug; 43(4):413-22. PubMed ID: 25676130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rise of Clostridium difficile infection in lung transplant recipients in the modern era.
    Lee JT; Hertz MI; Dunitz JM; Kelly RF; D'Cunha J; Whitson BA; Shumway SJ
    Clin Transplant; 2013; 27(2):303-10. PubMed ID: 23316931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Clostridioides difficile infection characterizations, risks, and outcomes in allogeneic hematopoietic stem cell and solid organ transplant recipients.
    Obeid KM; Sapkota S; Cao Q; Richmond S; Watson AP; Karadag FK; Young JH; Pruett T; Weisdorf DJ; Ustun C
    Transpl Infect Dis; 2022 Feb; 24(1):e13720. PubMed ID: 34455662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant Recipients.
    Ganetsky A; Han JH; Hughes ME; Babushok DV; Frey NV; Gill SI; Hexner EO; Loren AW; Luger SM; Mangan JK; Martin ME; Smith J; Freyer CW; Gilmar C; Schuster M; Stadtmauer EA; Porter DL
    Clin Infect Dis; 2019 May; 68(12):2003-2009. PubMed ID: 30256954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter study to define the epidemiology and outcomes of Clostridioides difficile infection in pediatric hematopoietic cell and solid organ transplant recipients.
    Mayer EF; Maron G; Dallas RH; Ferrolino J; Tang L; Sun Y; Danziger-Isakov L; Paulsen GC; Fisher BT; Vora SB; Englund J; Steinbach WJ; Michaels M; Green M; Yeganeh N; Gibson JE; Dominguez SR; Nicholson MR; Dulek DE; Ardura MI; Rajan S; Gonzalez BE; Beneri C; Herold BC
    Am J Transplant; 2020 Aug; 20(8):2133-2142. PubMed ID: 32064754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.